Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial

Completed · Not applicable

Conditions studied: Childhood Cancers

In brief

The investigators have developed a parent social-cognitive processing intervention (P-SCIP) to help decrease distress among parent caregivers of children undergoing hematopoietic stem cell transplant (HSCT). The investigators will evaluate the efficacy of P-SCIP in reducing short- and long-term distress and parenting stress among 300 parents of children undergoing HSCT. P-SCIP will be delivered during the child's inpatient HSCT hospitalization and is specifically designed to improve parent social (e.g., sharing concerns) and cognitive (e.g., acceptance) processing of the transplant experience. The intervention includes five in-person sessions that are accompanied by an interactive CD-ROM. The CD-ROM complements the materials in the in-person sessions and provides parents with the opportunity to enhance and deepen their cognitive and social processing of the HSCT experience. The intervention will be tested against best-practices psychosocial care (BPC) available in four enriched pediatric HSCT settings across the United States. P-SCIP will be provided to both Spanish- and English-speaking parents. Participants will complete measures of psychological distress, well-being, and social and cognitive processing at the time of HSCT, two, six and twelve months after HSCT. Research questions will address the effects of P-SCIP versus BPC on parent psychological adaptation and social and cognitive processing, as well as evaluate parent personal resources as well as child medical course variables that contribute to intervention response. The investigators will also examine barriers to participation in the intervention by comparing barriers to participation among parents who refuse participation in the trial and parents who accept.

Key facts

Study ID

NCT00939380

Run by

Rutgers, The State University of New Jersey

People needed

212

Starts

2010-05-01

Expected to finish

2015-05-01

Last updated by the study team

2016-03-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• biological or foster parent of children under 19 years of age who are scheduled for HSCT within the next month
• participant is the primary caregiver
• participant must have phone service
• caregiver speaks, reads, and writes English or Spanish (Spanish is for Childrens Hospital Los Angeles and Columbia University only)

You may not qualify if…

• pediatric patient has a diagnosis of medulloblastoma or other cancer of the brain

Where it is running

• Childrens Hospital Los Angeles — Los Angeles, California, United States
• Emory University/Childrens Healthcare of Atlanta — Atlanta, Georgia, United States
• Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey, United States
• Memorial Sloan-Kettering Cancer Center — New York, New York, United States
• Columbia University — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.